Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,340 /  薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04472975 (ClinicalTrials.gov)	January 1, 1996	3/7/2020	Prescription Drug Safety and Effectiveness in Multiple Sclerosis	Disease-modifying Drug Safety and Effectiveness in Multiple Sclerosis [DRUMS]	Multiple Sclerosis	Drug: Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS	University of British Columbia	University of Manitoba;Dalhousie University;University of Saskatchewan;Alberta Health Services;University of Alberta	Completed	18 Years	N/A	All	35000		NULL